{"news_desk": "Business", "print_page": "3", "section_name": "Business Day", "subsection_name": "DealBook", "byline": {"original": "By ANDREW POLLACK", "person": [{"rank": 1, "role": "reported", "firstname": "Andrew", "organization": "", "lastname": "POLLACK"}]}, "abstract": "Biotech firm Celgene agrees to buy Receptos for $7.2 billion.", "type_of_material": "News", "word_count": "489", "lead_paragraph": "Celgene, a New Jersey biotechnology company, will pay $232 a share for Receptos, which is developing a drug for autoimmune diseases.", "pub_date": "2015-07-15T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Celgene Agrees to $7.2 Billion Deal for Receptos", "print_headline": "Celgene Agrees to Buy Autoimmune Drug Maker"}, "snippet": "Celgene, a New Jersey biotechnology company, will pay $232 a share for Receptos, which is developing a drug for autoimmune diseases.", "multimedia": [], "web_url": "http://www.nytimes.com/2015/07/15/business/dealbook/celgene-agrees-to-7-2-billion-deal-for-receptos.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Celgene Corporation", "name": "organizations"}, {"rank": "2", "is_major": "Y", "value": "Receptos Inc.", "name": "organizations"}, {"rank": "3", "is_major": "N", "value": "Mergers, Acquisitions and Divestitures", "name": "subject"}, {"rank": "4", "is_major": "N", "value": "Biotechnology and Bioengineering", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Autoimmune Diseases", "name": "subject"}], "blog": [], "_id": "55a584c438f0d8361af04699", "source": "The New York Times"}